drugset

drugset / Trial / NCT00202124

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

NCT00202124 ↗

Phase 4 Completed 12 enrolled Queen's University

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether tryptophan is effective in the treatment of mild to moderate Alzheimer's Disease (AD).

Timeline

Start: 2001-04
Primary completion: —
Completion: 2002-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tryptophan	Other / unclassified	1 g	—

Indications